One of the most exciting possibilities in human therapeutics is that stem cells (embryonic or adult) may compensate for cell loss in disease, with functional recovery.
This has received considerable publicity in the lay press.
Much work remains to be done to turn stem cell therapy into a practical reality for major degenerative diseases, especially those affecting the nervous system.
Medical scientists and journalists should work together in ensuring that the general public has a realistic understanding of the likely time frame in which benefits from stem cell therapies will be realised.
- 1. Alison MR, Poulsom R, Forbes S, et al. An introduction to stem cells. J Pathol 2002; 197: 419-423.
- 2. Kakulas BA. Regeneration of skeletal muscle in the Rottnest quokka. Aust J Exp Biol Med Sci 1966; 44: 673-688.
- 3. Blau HM, Webster C, Pavlath GK. Defective myoblasts identified in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 1983; 80: 4856-4860.
- 4. Partridge T, Lu QL, Morris G, et al. Is myoblast transplantation effective? Nat Med 1998; 4: 1208-1209.
- 5. Rossi F, Cattaneo E. Opinion — neural stem cell therapy for neurological diseases: dreams and reality [review]. Nat Rev Neurosci 2002; 3: 401-409.
- 6. Bonnet D. Haematopoietic stem cells [review]. J Pathol 2002; 197: 430-440.
- 7. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313.
- 8. Li Y, Chen J, Chopp M. Adult bone marrow transplantation after stroke in adult rats. Cell Transplant 2001; 10: 31-40.
- 9. Bjorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 2000; 3: 537-544.
- 10. Kordower JH, Freeman TB, Snow BJ, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. N Engl J Med 1995; 332: 1118-1124.
- 11. Wenning GK, Odin P, Morrish P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997; 42: 95-107.
- 12. Hauser RA, Freeman TB, Snow BJ, et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 1999; 56: 179-87.
- 13. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710-719.
- 14. Bjorklund LM, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002; 99: 2344-2349.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.